BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10480344)

  • 1. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
    Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
    J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
    Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
    J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters.
    Mohammedi L; Doula FD; Mesli F; Senhadji R
    Afr Health Sci; 2019 Jun; 19(2):2140-2146. PubMed ID: 31656498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
    Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
    Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
    Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U
    Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
    Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
    Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
    Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
    Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
    Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
    Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
    Reis-Filho JS; Savage K; Lambros MB; James M; Steele D; Jones RL; Dowsett M
    Mod Pathol; 2006 Jul; 19(7):999-1009. PubMed ID: 16648863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.
    Peurala E; Koivunen P; Haapasaari KM; Bloigu R; Jukkola-Vuorinen A
    Breast Cancer Res; 2013 Jan; 15(1):R5. PubMed ID: 23336272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
    Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse.
    Kastner A; Moyse E; Bauer S; Jourdan F; Brun G
    J Neurochem; 2000 Jun; 74(6):2343-9. PubMed ID: 10820194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.
    Hong J; Shah NN; Thomas TJ; Gallo MA; Yurkow EJ; Thomas T
    Oncol Rep; 1998; 5(5):1025-33. PubMed ID: 9683804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
    Vos CB; Ter Haar NT; Peterse JL; Cornelisse CJ; van de Vijver MJ
    J Pathol; 1999 Feb; 187(3):279-84. PubMed ID: 10398079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.
    Wang QS; Papanikolaou A; Sabourin CL; Rosenberg DW
    Carcinogenesis; 1998 Nov; 19(11):2001-6. PubMed ID: 9855016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCND1 mRNA overexpression is highly related to estrogen receptor positivity but not to proliferative markers in primary breast cancer.
    Spyratos F; Andrieu C; Vidaud D; Briffod M; Vidaud M; Lidereau R; Bièche I
    Int J Biol Markers; 2000; 15(3):210-4. PubMed ID: 11012095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
    PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.